JP2024525815A5 - - Google Patents
Info
- Publication number
- JP2024525815A5 JP2024525815A5 JP2024502111A JP2024502111A JP2024525815A5 JP 2024525815 A5 JP2024525815 A5 JP 2024525815A5 JP 2024502111 A JP2024502111 A JP 2024502111A JP 2024502111 A JP2024502111 A JP 2024502111A JP 2024525815 A5 JP2024525815 A5 JP 2024525815A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- cells
- nucleic acids
- cell receptor
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163222130P | 2021-07-15 | 2021-07-15 | |
| US63/222,130 | 2021-07-15 | ||
| US202263300905P | 2022-01-19 | 2022-01-19 | |
| US63/300,905 | 2022-01-19 | ||
| US202263344221P | 2022-05-20 | 2022-05-20 | |
| US63/344,221 | 2022-05-20 | ||
| PCT/US2022/036841 WO2023287803A2 (en) | 2021-07-15 | 2022-07-12 | Compositions and methods for making novel t-cell receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525815A JP2024525815A (ja) | 2024-07-12 |
| JP2024525815A5 true JP2024525815A5 (enExample) | 2025-06-16 |
Family
ID=84919648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502111A Pending JP2024525815A (ja) | 2021-07-15 | 2022-07-12 | 新規のｔ細胞受容体を作製するための組成物および方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12606936B2 (enExample) |
| EP (1) | EP4370542A4 (enExample) |
| JP (1) | JP2024525815A (enExample) |
| WO (1) | WO2023287803A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4281569A4 (en) * | 2021-01-25 | 2025-04-02 | The Regents Of The University Of California | Methods and compositions for labeling and selecting antigen-specific T cells |
| IL325949A (en) * | 2023-07-18 | 2026-03-01 | Heligenics Inc | Method for producing and screening multi-functional chimeric biologic libraries |
| WO2025032194A1 (en) * | 2023-08-08 | 2025-02-13 | Ospedale San Raffaele S.R.L. | T-cell receptors |
| CN117338914B (zh) * | 2023-10-27 | 2024-09-06 | 中山市珈钰生物医药有限公司 | 一种同种异体树突细胞肿瘤疫苗及其制备方法和应用 |
| WO2025160372A1 (en) * | 2024-01-24 | 2025-07-31 | Hifibio Sas | Methods for identification of cognate pairs of ligands and receptors |
| WO2026043868A1 (en) * | 2024-08-20 | 2026-02-26 | Amgen Inc. | A cell-based platform for identifying native protein-protein interactions in mammalian display libraries |
| WO2026040998A1 (zh) * | 2024-08-20 | 2026-02-26 | 上海灵识质源生物技术有限公司 | Tp53突变体表位肽和特异性t细胞受体及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2477648T1 (sl) * | 2009-09-15 | 2022-09-30 | The Board Of Trustees Of The Leland Stanford Junior University | Sinergijska terapija proti CD47 za krvne rake |
| AU2016326734B2 (en) * | 2015-09-25 | 2022-07-07 | Abvitro Llc | High throughput process for T cell receptor target identification of natively-paired T cell receptor sequences |
| EP3202783A1 (en) * | 2016-02-02 | 2017-08-09 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Engineered antigen presenting cells and uses thereof |
| WO2019077062A1 (en) * | 2017-10-18 | 2019-04-25 | Vivia Biotech, S.L. | C-CELLS ACTIVATED BY BIT |
| KR20210106527A (ko) * | 2018-12-20 | 2021-08-30 | 페킹 유니버시티 | 바코드화 가이드 rna 구축물을 사용한 고효율의 유전자 스크리닝을 위한 조성물 및 방법 |
| CN114127305A (zh) | 2019-05-23 | 2022-03-01 | 麻省理工学院 | 经由逆转录病毒表面展示的配体发现和基因递送 |
-
2022
- 2022-07-12 EP EP22842767.0A patent/EP4370542A4/en active Pending
- 2022-07-12 JP JP2024502111A patent/JP2024525815A/ja active Pending
- 2022-07-12 WO PCT/US2022/036841 patent/WO2023287803A2/en not_active Ceased
- 2022-07-12 US US17/863,200 patent/US12606936B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12606936B2 (en) | Compositions and methods for making novel T-cell receptors | |
| US20250025506A1 (en) | Engineered safety in cell therapy | |
| EP3700926A1 (en) | Methods of making chimeric antigen receptor-expressing cells | |
| JP2021532742A5 (enExample) | ||
| JP2025511151A5 (enExample) | ||
| CN106536558A (zh) | 转基因遗传标签和使用的方法 | |
| CN104780939A (zh) | 用于细胞免疫治疗的方法和组合物 | |
| EP4036109A2 (en) | Methods of making chimeric antigen receptor-expressing cells | |
| US12152251B2 (en) | T cells with improved functionality | |
| CN110511912A (zh) | 免疫细胞的功能调节 | |
| EP4210733B1 (en) | System for inducible expression of an adapter in immune cells | |
| CA3229746A1 (en) | Methods of making chimeric antigen receptor-expressing cells | |
| CN117683139A (zh) | 组成型嵌合细胞因子受体及表达其的免疫细胞及应用 | |
| JP2025518033A (ja) | 免疫細胞クリスパースクリーニングのための方法及び組成物 | |
| CN115724996A (zh) | 含有膜表面结构域的多肽及其用途 | |
| JP2025526409A (ja) | 細胞療法を補完するための導入遺伝子をコードするウイルス | |
| EP4486373A1 (en) | Allogeneic therapeutic cells | |
| WO2023242434A1 (en) | Modified immune cells | |
| CN112251452A (zh) | Til/tcr-t细胞治疗平台 | |
| WO2026016944A1 (zh) | 腺病毒载体及其应用 | |
| KR20250013199A (ko) | 세포 요법 작제물의 비-바이러스 전달 | |
| HK40115321A (en) | Allogeneic therapeutic cells | |
| CN120988141A (zh) | 一种过表达cd2的双靶向嵌合抗原受体及其应用 | |
| US20240366670A1 (en) | Allogenic therapeutic cells with reduced risk of immune rejection | |
| EA050762B1 (ru) | Аллогенные терапевтические клетки |